Lyell Competitors and Similar CompaniesClear all

Jounce Therapeutics's competitors and similar companies include NovoCure.

	Jounce Therapeutics Jounce Therapeutics is a clinical-stage immunotherapy company.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Founding Date	Founding Date 2013	Founding Date 2000
Type	Type Public	Type Public
Tags	Tags Healthcare Technology healthtech oncology platform therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations Cambridge, US HQ	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 1302% increase	Employees 1,488
Valuation ($)	Valuation ($) 101.6 m	Valuation ($) 1.8 b
Financial
Net income	Net income ($50.9m) (FY, 2022)	Net income ($136.2m) (FY, 2025)

For sources of this data, please see the company profile

Saint Helier, JE

Employees

1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

Financial